Thomas Nerreter

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Maik Luu, Zeno Riester, Adrian Baldrich et al. · Nature Communications · 2021 · 688 citations · Full text

Life Sciences, Immunology, Oncology +17

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

Katrin Mestermann, Theodoros Giavridis, Justus Weber et al. · Science Translational Medicine · 2019 · 503 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

Hardikkumar Jetani, Irene García‐Cadenas, Thomas Nerreter et al. · Leukemia · 2018 · 201 citations

Medicine, Cancer Biology, Oncology +15

ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models

Lars Wallstabe, Claudia Göttlich, Lena C. Nelke et al. · JCI Insight · 2019 · 192 citations · Full text

Medicine, Immunology, Oncology +17

Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T

Thomas Nerreter, Sebastian Letschert, Ralph Götz et al. · Nature Communications · 2019 · 171 citations · Full text

Life Sciences, Cell Biology, Immunology +17